US stock correlation matrix and portfolio risk analysis to understand how your holdings interact with each other and affect overall portfolio risk. We help you identify concentration risks and provide recommendations for improving portfolio diversification across sectors and asset classes. Our platform offers correlation analysis, risk contribution, and diversification scoring for comprehensive analysis. Optimize portfolio construction with our comprehensive correlation and risk analysis tools for better risk-adjusted returns.
This analysis evaluates CME Group’s valuation following a 6% pullback in its share price over the 30 days ending April 24, 2026, despite the firm delivering a 12.58% 1-year total shareholder return (TSR) and 76.19% 3-year TSR. Conflicting outputs from market-relative fair value modeling and discount
CME Group Inc. (CME) - Valuation Assessment Following Near-Term Share Price Pullback - Equity Raise
CME - Stock Analysis
4250 Comments
1591 Likes
1
Yali
Influential Reader
2 hours ago
Effort like that is rare and valuable.
👍 299
Reply
2
Aracelly
Consistent User
5 hours ago
Well-presented and informative — helps contextualize market movements.
👍 156
Reply
3
Correon
Active Contributor
1 day ago
This feels like a warning sign.
👍 283
Reply
4
Itsuki
Insight Reader
1 day ago
Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
👍 206
Reply
5
Javius
Trusted Reader
2 days ago
Price trends suggest a mixture of consolidation and selective upward movement across key sectors.
👍 265
Reply
© 2026 Market Analysis. All data is for informational purposes only.